Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell surface markers in hematologic malignancies.

A S Freedman, L M Nadler

    Seminars in Oncology
    |June 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Cell surface markers reveal greater diversity in human T, B, and myeloid neoplasms. This allows correlating malignant cells to normal counterparts for better understanding of cancer biology and behavior.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia.

    Leukemia & lymphoma·2015
    Same author

    Alloanergization of human T cells results in expansion of alloantigen-specific CD8(+) CD28(-) suppressor cells.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
    Same author

    Germline copy number variation associated with Mendelian inheritance of CLL in two families.

    Leukemia·2012
    Same author

    (90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma.

    Bone marrow transplantation·2011
    Same author

    A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome.

    Annals of oncology : official journal of the European Society for Medical Oncology·2011
    Same author

    A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL.

    Leukemia·2010
    Same journal

    A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

    Seminars in oncology·2026
    Same journal

    Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

    Seminars in oncology·2026
    Same journal

    PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

    Seminars in oncology·2026
    Same journal

    Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

    Seminars in oncology·2026
    Same journal

    Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

    Seminars in oncology·2026
    Same journal

    Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

    Seminars in oncology·2026
    See all related articles

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • Standard morphologic and histochemical techniques underestimated the heterogeneity of human T, B, and myeloid neoplasms.
    • Cell surface markers offer a more detailed view of cancer cell characteristics.

    Purpose of the Study:

    • To highlight the heterogeneity of human hematopoietic neoplasms using cell surface markers.
    • To correlate malignant lymphoid and myeloid cells with their normal counterparts.
    • To improve the understanding of the biologic and clinical behavior of these malignancies.

    Main Methods:

    • Utilizing cell surface markers specific for lineage and differentiation state.
    • Comparing malignant cells to normal hematopoietic cell populations.

    Related Experiment Videos

    Main Results:

    • Cell surface markers identified significantly more heterogeneity in human T, B, and myeloid neoplasms than previously recognized.
    • Malignant lymphoid and myeloid cells can be correlated to their normal cellular counterparts based on differentiation markers.

    Conclusions:

    • The diversity of normal hematopoietic ontogeny, differentiation, and function is reflected in hematopoietic malignancies.
    • Further characterization of cell surface molecules and normal cell subpopulations will enhance understanding of neoplasm behavior.